91 related articles for article (PubMed ID: 25297985)
1. In vivo remodelling of vascularizing engineered tissues.
Chamberlain MD; West ME; Lam GC; Sefton MV
Ann Biomed Eng; 2015 May; 43(5):1189-200. PubMed ID: 25297985
[TBL] [Abstract][Full Text] [Related]
2. Review of vascularised bone tissue-engineering strategies with a focus on co-culture systems.
Liu Y; Chan JK; Teoh SH
J Tissue Eng Regen Med; 2015 Feb; 9(2):85-105. PubMed ID: 23166000
[TBL] [Abstract][Full Text] [Related]
3. The healing of bony defects by cell-free collagen-based scaffolds compared to stem cell-seeded tissue engineered constructs.
Lyons FG; Al-Munajjed AA; Kieran SM; Toner ME; Murphy CM; Duffy GP; O'Brien FJ
Biomaterials; 2010 Dec; 31(35):9232-43. PubMed ID: 20863559
[TBL] [Abstract][Full Text] [Related]
4. The role of biomaterials in the direction of mesenchymal stem cell properties and extracellular matrix remodelling in dermal tissue engineering.
Schneider RK; Anraths J; Kramann R; Bornemann J; Bovi M; Knüchel R; Neuss S
Biomaterials; 2010 Nov; 31(31):7948-59. PubMed ID: 20688387
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-Inducible Factor Drives Vascularization of Modularly Assembled Engineered Tissue.
Lam GC; Sefton MV
Tissue Eng Part A; 2019 Aug; 25(15-16):1127-1136. PubMed ID: 30585759
[TBL] [Abstract][Full Text] [Related]
6. The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodelling in three-dimensional collagen scaffolds.
Schneider RK; Puellen A; Kramann R; Raupach K; Bornemann J; Knuechel R; Pérez-Bouza A; Neuss S
Biomaterials; 2010 Jan; 31(3):467-80. PubMed ID: 19815272
[TBL] [Abstract][Full Text] [Related]
7. CD34/CD133 enriched bone marrow progenitor cells promote neovascularization of tissue engineered constructs in vivo.
Herrmann M; Binder A; Menzel U; Zeiter S; Alini M; Verrier S
Stem Cell Res; 2014 Nov; 13(3 Pt A):465-77. PubMed ID: 25460607
[TBL] [Abstract][Full Text] [Related]
8. Tuning graft- and host-derived vascularization in modular tissue constructs: a potential role of HIF1 activation.
Lam GC; Sefton MV
Tissue Eng Part A; 2015 Feb; 21(3-4):803-16. PubMed ID: 25379774
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional engineered bone from bone marrow stromal cells and their autogenous extracellular matrix.
Syed-Picard FN; Larkin LM; Shaw CM; Arruda EM
Tissue Eng Part A; 2009 Jan; 15(1):187-95. PubMed ID: 18759662
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia induces osteogenic/angiogenic responses of bone marrow-derived mesenchymal stromal cells seeded on bone-derived scaffolds via ERK1/2 and p38 pathways.
Zhou Y; Guan X; Wang H; Zhu Z; Li C; Wu S; Yu H
Biotechnol Bioeng; 2013 Jun; 110(6):1794-804. PubMed ID: 23296944
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast response to hypoxia: the relationship between angiogenesis and matrix regulation.
Steinbrech DS; Longaker MT; Mehrara BJ; Saadeh PB; Chin GS; Gerrets RP; Chau DC; Rowe NM; Gittes GK
J Surg Res; 1999 Jun; 84(2):127-33. PubMed ID: 10357908
[TBL] [Abstract][Full Text] [Related]
12. Human fibroblast-derived extracellular matrix constructs for bone tissue engineering applications.
Tour G; Wendel M; Tcacencu I
J Biomed Mater Res A; 2013 Oct; 101(10):2826-37. PubMed ID: 23471711
[TBL] [Abstract][Full Text] [Related]
13. The influence of construct scale on the composition and functional properties of cartilaginous tissues engineered using bone marrow-derived mesenchymal stem cells.
Buckley CT; Meyer EG; Kelly DJ
Tissue Eng Part A; 2012 Feb; 18(3-4):382-96. PubMed ID: 21919793
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous cultivation of human endothelial-like differentiated precursor cells and human marrow stromal cells on beta-tricalcium phosphate.
Henrich D; Seebach C; Kaehling C; Scherzed A; Wilhelm K; Tewksbury R; Powerski M; Marzi I
Tissue Eng Part C Methods; 2009 Dec; 15(4):551-60. PubMed ID: 19199563
[TBL] [Abstract][Full Text] [Related]
15. Anterior cruciate ligament constructs fabricated from human mesenchymal stem cells in a collagen type I hydrogel.
Nöth U; Schupp K; Heymer A; Kall S; Jakob F; Schütze N; Baumann B; Barthel T; Eulert J; Hendrich C
Cytotherapy; 2005; 7(5):447-55. PubMed ID: 16236634
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of bone marrow-derived endothelial progenitor cell/mesenchymal stem cell interaction in co-culture and its implications in angiogenesis.
Aguirre A; Planell JA; Engel E
Biochem Biophys Res Commun; 2010 Sep; 400(2):284-91. PubMed ID: 20732306
[TBL] [Abstract][Full Text] [Related]
17. Stem cells and scaffolds for vascularizing engineered tissue constructs.
Luong E; Gerecht S
Adv Biochem Eng Biotechnol; 2009; 114():129-72. PubMed ID: 19082932
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of a tissue-engineered periosteum with acellular dermal matrix and cultured mesenchymal stem cells.
Schönmeyr B; Clavin N; Avraham T; Longo V; Mehrara BJ
Tissue Eng Part A; 2009 Jul; 15(7):1833-41. PubMed ID: 19125645
[TBL] [Abstract][Full Text] [Related]
19. Composite implantation of mesenchymal stem cells with endothelial progenitor cells enhances tissue-engineered bone formation.
Usami K; Mizuno H; Okada K; Narita Y; Aoki M; Kondo T; Mizuno D; Mase J; Nishiguchi H; Kagami H; Ueda M
J Biomed Mater Res A; 2009 Sep; 90(3):730-41. PubMed ID: 18570318
[TBL] [Abstract][Full Text] [Related]
20. Construction of ureteral grafts by seeding bone marrow mesenchymal stem cells and smooth muscle cells into bladder acellular matrix.
Liao W; Yang S; Song C; Li X; Li Y; Xiong Y
Transplant Proc; 2013 Mar; 45(2):730-4. PubMed ID: 23498814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
